Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
[1] [2] According to NICE guideline NG28 (Type 2 diabetes in adults: management), GLP-1 receptor agonists may be considered when metformin is contraindicated or not tolerated, or when other treatments have not achieved adequate glycaemic control, particularly in patients with a BMI 35 kg/m (or lower in certain ethnic groups) or when weight loss would provide additional clinical benefit
UK regulatory status retatrutide holds no MHRA marketing authorisation and is supplied for laboratory research use only as of 2026
Apart from these, despite favorably influencing hepatic steatosis, no clinical evidence has been reported on MASH amelioration by other frequently used antidiabetic drugs, i.e., sodiumglucose cotransporter 2 (SGLT2) inhibitors and insulin
Semaglutide, a GLP-1 receptor agonist approved for type 2 diabetes and weight management, is frequently prescribed alongside thyroid medications like levothyroxine
US$ 27.20
US$ 21.11
US$ 24.95
US$ 25.68
